Furthermore, data from bioinformatical analyses have implicated that ANAX1, CYR61, and VIM are mainly associated with the development of PAAD and GBM, while CEACAM1 and EPHA2 are associated with adrenocortical carcinoma. The gene discussed is CEACAM1; the disease is pancreatic adenocarcinoma.